Zeria Pharmaceutical Co Ltd
TSE:4559
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zeria Pharmaceutical Co Ltd
Cash from Financing Activities
Zeria Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Cash from Financing Activities
-¥6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥721.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-9%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥58.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥137.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥307.9B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-25%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
-¥337.4B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
Zeria Pharmaceutical Co Ltd
Glance View
Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,690 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.
See Also
What is Zeria Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-6B
JPY
Based on the financial report for Dec 31, 2025, Zeria Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -6B JPY.
What is Zeria Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-61%
Over the last year, the Cash from Financing Activities growth was 46%. The average annual Cash from Financing Activities growth rates for Zeria Pharmaceutical Co Ltd have been -1% over the past three years , -61% over the past five years .
